Potential Utility of A Proliferation-Inducing Ligand (APRIL) in Colorectal Cancer

Monika Zajkowska, Karolina Orywal, Mariusz Gryko, Carmine Stolfi · 2024

Read Potential Utility of A Proliferation-Inducing Ligand (APRIL) in Colorectal Cancer by Monika Zajkowska, Karolina Orywal, Mariusz Gryko, Carmine Stolfi (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11641194.txt.

Description

Monika Zajkowska, Karolina Orywal and Mariusz Gryko review what APRIL, a proliferation-inducing ligand, could do for colorectal cancer care. APRIL belongs to the tumour necrosis factor family and is overproduced in many cancers, this one included. In healthy life it helps antibody switching and plasma cell survival, and blocking it is already a target in immune disease.

The review gathers evidence on how APRIL feeds the start and growth of colorectal cancer. Its blood level can flag patients with the disease, though it cannot yet tell a benign growth from a malignant one. The authors see real promise in APRIL as both a detection marker and a treatment target.

Catalog record

CREATORMonika Zajkowska, Karolina Orywal, Mariusz Gryko, Carmine Stolfi
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE31 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11641194

Browse the full library · About the Tower of Babel